Huahai Pharma Raises Funds for Digital Manufacturing and API Platform
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) plans to raise RMB 1.56 billion (USD...
China-based Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521) plans to raise RMB 1.56 billion (USD...
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly...
China-based intraoperative nerve monitoring technology developer Beijing Huashen Shengdian Medical Technology Co., Ltd has reportedly...
MoleculeMind, an artificial intelligence (AI)-empowered protein design platform based in Beijing, has reportedly raised over...
Beijing Chunlizhengda Medical Instruments Co., Ltd (HKG: 1858, SHA: 688236) is poised to acquire a...
Shanghai-based REMD, a leading manufacturer of irreversible electroporation devices, has reportedly raised over RMB 100...
Hygea Medical Technology Co., Ltd, a leading minimally invasive device maker for oncology indications based...
China-based Centre Testing International Group Co., Ltd (CTI), a leading third-party testing and qualification services...
Suzhou-based new drug developer Vincentage has reportedly raised close to RMB 100 million (USD 14.6...
China-based Jiangsu Recbio Technology Co., Ltd has announced the completion of the first tranche of...
China-based high-value medical device firm Mingche Biotechnology (Suzhou) Co., Ltd has reportedly raised “tens of...
Hangzhou Dessight Biomedical has reportedly raised “tens of millions” of renminbi in a Pre-Series A...
China-based Ganzhou Hemay Pharmaceutical Co., Ltd, an innovative drug developer focused on autoimmune diseases and...
Neurodawn Pharmaceutical Co., Ltd, a central nervous system (CNS) drug developer based in Nanjing, has...
Macrolux, an endoscopy intervention solutions provider based in Shenzhen, has reportedly raised close to RMB...
China-based Lifetech Scientific Corporation (HKG: 1302) has announced a partnership agreement with compatriot firm Jenscare...
Forlong Biotechnology, a synthetic immunology-driven protein drug developer based in Suzhou, has reportedly raised upwards...
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) is set to make another public offering...
Swiss pharmaceutical giant Roche (SWX: RO) released its 2022 financial report this week, recording CHF...
China-based Zhejiang Gongdong Medical Technology Co., Ltd is set to acquire core assets of US...